SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.

Altre lingue Shandong Sinobioway Biomedicine Co., Ltd.

Azioni

002581

CNE1000012Y5

Prezzo di chiusura Shenzhen S.E. Altri mercati azionari 00:00:00 07/05/2024			Variaz. 5gg	Var. 1 gen.
13,82 ^CNY	+0,73%		-0,36%	-5,34%

29/04	Shandong Sinobioway Biomedicine Co., Ltd. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI
29/04	Shandong Sinobioway Biomedicine Co., Ltd. riporta i risultati degli utili per l'intero anno conclusosi il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	29/04
Sinobioway Biomedicine's Unit to Relocate	12/12
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23
Shandong Sinobioway Biomedicine Co., Ltd.(XSEC:002581) added to S&P Global BMI Index	18/09/23
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	30/08/23
Sinobioway Biomedicine Taps Builders for Planned Industrial Park	17/08/23
Sinobioway Biomedicine Earmarks 1 Billion Yuan for Pharmaceutical Industrial Park	27/04/23
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	26/04/23
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	26/04/23
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	30/10/22
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	29/08/22
Shandong Sinobioway Biomedicine Co., Ltd. Announces Executive Appointments	23/08/22
Shenzhen Yilian Technology Limited Company and Shenzhen Jialian Private Equity Investment Fund Management Co., Ltd. won the auction to acquire 8.67% stake in Shandong Sinobioway Biomedicine Co., Ltd. from Beijing Sinobioway Group Co., Ltd. for CNY 77.85 million.	02/06/22
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	29/04/22
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	29/10/21
Xiamen Hengxing Group Co., Ltd. acquired Shandong Sinobioway Biomedicine Co., Ltd. from Shenzhen Sandao Investment Management Enterprise (Limited Partnership) for CNY 200 million.	18/09/21
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	30/08/21
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	28/04/21
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	26/10/20

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Shandong Sinobioway Biomedicine Co., Ltd.

Azioni

002581

CNE1000012Y5

Altre lingue

Filtri